Download - WHOCC

QV09G
CARDIOVASCULAR SYSTEM
This group comprises radiopharmaceuticals for mycardial scintigraphy, ejection
fraction measurements, and vascular disorders.
QV09GA
Technetium ( 99m Tc) compounds
Labelled cells (erythrocytes) for the investigation of cardiocvascular function are
classified in this group. No subdivision is made between in vitro or in vivo
labelling.
Pertechnetate for thyroid imaging is classified in QV09F - Thyroid.
QV09GB
QV09GX
Iodine ( 125 I) compounds
Other cardiovascular system diagnostic radiopharmaceuticals
QV09H
INFLAMMATION AND INFECTION DETECTION
This group comprises agents for the detection of inflammation and infection.
Labelled blood cells are classified in this group. Agents that are used for the
labelling of these cells can also be classified elsewhere, e.g. technetiumexametazime
is classified in QV09A - Central nervous system. No subdivision is
made for the type of labelled cells (erythrocytes, granulocytes or autologous etc.).
QV09HA
QV09HB
QV09HX
Technetium ( 99m Tc) compounds
Indium ( 111 In) compounds
Other diagnostic radiopharmaceuticals for inflammation and infection detection
QV09I
TUMOUR DETECTION
This group comprises monoclonal antibodies and other compounds used for tumour
detection.
QV09IA
QV09IB
QV09IX
Technetium ( 99m Tc) compounds
Indium ( 111 In) compounds
Other diagnostic radiopharmaceuticals for tumour detection
Gallium-citrate used for non-specific tumour localisation is classified in QV09H -
inflammation and infection detection. Thallium-chloride used for tumour detection
is classified in QV09G - Cardiovascular system. Iobenguane ( 131 I) in low dose is
classified here while high dose for therapy is classified in QV10X - Other
therapeutic radiopharmaceuticals.
184